Category
Adagrasib
CAS Number
NA
Molecular Formula
C₃₁H₄₃N₇O₃
Molecular Weight
561.72 g/mol
Synonym

(S)-Tert-butyl 4-(7-benzyl-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)-2-(cyanomethyl)piperazine-1-carboxylate

Keywords
Aromatics
Pharmaceutical Standards
Intermediates
Fine Chemicals
Nitrosamine Standards
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Adagrasib Impurity 2 is a specific process- or degradation-related impurity associated with Adagrasib. It can form during the drug’s synthesis, handling, or storage. Like other impurities, it is identified, characterized, and strictly controlled within regulatory limits to ensure the safety, efficacy, and quality of the final pharmaceutical product.